TNFRSF18 and type 1 diabetes mellitus: GITR+ Tregs are markedly lower in frequency in autoimmune diseases including type 1 diabetes and systemic lupus erythematous, and increasing the frequency of GITR+ Tregs is associated with the remission in these conditions [56–59].